Clinical Trial: Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232056) titled 'Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy' on Nov. 14.

Brief Summary: Older women (>=65 years) with HR+ non-metastatic breast cancer experience high symptom burden and reduced quality of life during aromatase inhibitor (AI) therapy. This hierarchical 2x2 factorial randomized controlled trial will test two interventions: (1) a clinic-level geriatric oncology assessment and support program (GOAL-AI) and (2) a patient-level CBT-based coping skills training (CST-AI). The study aims to improve pain, symptom burden, and health-related quality of life compared to enhanced usual ...